| 5 min read
Stem cell therapy for Parkinson’s disease, discontinuation of Pfizer’s GLP-1 drug, a pig liver clinical trial, and more biotech and pharma news from this week.
| 4 min read
Biotech and pharma leaders reveal the neurological therapies in development that they’re most excited about.
| 4 min read
Uniquity Bio seeks to investigate compounds that might otherwise sit on the shelf forever. Their lead compound appears poised to prove their model works.News
| 3 min read
Vaxart’s orally administered vaccine tablet was safe and elicited mucosal immunity in older adults.
| 3 min read
A statistical model using two measures of brain activity could anticipate if people given an injection would be in severe pain for the next month.
| 5 min read
Insights from the AD/PD meeting, continued fallout from the FDA layoffs, hope for GLP-1 drugs in Alzheimer’s disease, and more led industry news this week.
| 4 min read
By using phages to deliver genes for therapeutic proteins, biologic drug delivery could become much easier.
| 4 min read
In a Phase 2b trial, Khondrion’s sonlicromanol led to significant health benefits for patients with mitochondrial disease linked to a common mutation.
| 3 min read
Immune cells carried an antioxidant to a mouse’s cardiac muscle cells, which had been damaged by a heart attack.
| 3 min read
A gene therapy targeting organs beyond the brain could improve quality of life and possibly extend survival in children with the neurodegenerative disease.
| 10 min read
Advances in GLP-1 research for diabetes and obesity, multiple sclerosis discoveries, and DNA editing are awarded in this year’s prestigious prize.
| 4 min read
From layoffs at the FDA, CDC, and NIH to a blood test for Alzheimer’s disease and a starfish-inspired diagnostic, the DDN team breaks down this week’s news.
| 3 min read
A new method for tracking dietary intake used DNA in stool to detect nutritional content from a broad range of foods.
| 3 min read
Omalizumab could be a better treatment for children with food allergies compared to oral immunotherapy, mainly due to fewer side effects.
| 4 min read
Researchers developed a PET probe that targets all immune cells to help diagnose and monitor inflammatory diseases.
| 4 min read
A landmark UTI drug approval, new hope for the amyloid hypothesis in Alzheimer’s disease, a brewing vaccine study controversy, and more led the news this week.
| 7 min read
A targeted interleukin-12 gene therapy plus chemotherapy increased survival in advanced ovarian cancer, setting the stage for a new first-line drug.
| 3 min read
Tamoxifen and a Mediterranean diet promoted bacterial communities that suppress breast tumor growth.
| 6 min read
ArsenalBio equips T cells with multiple weapons to identify, attack, and persist against tumors, bringing the power of CAR T cell technology to solid cancers.
| 2 min read
Antibiotics target bacteria, but new work in mice shows they also harm the mucus layer that protects the intestinal lining from microbes.
Page 1 of 29 - 562 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Discovering deeper insights into malaria research
Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
Accelerating RNA therapeutic testing with liver microphysiological platforms
Researchers can now study oligonucleotide delivery and efficacy in a system that models a real human liver.
Shining light on the subcellular proteome
Discover how innovative proteomics tools help researchers peer into once inaccessible organelles, allowing for new targets for drug discovery and development.
